Bharat Rasayan Ltd. Stock Hits 52-Week Low Amid Continued Downtrend

5 hours ago
share
Share Via
Bharat Rasayan Ltd., a key player in the Pesticides & Agrochemicals sector, recorded a fresh 52-week low of Rs.1647.15 on 21 Jan 2026, marking a significant milestone in its ongoing decline. The stock has endured a sustained downward trajectory, reflecting a combination of subdued financial performance and broader market pressures.
Bharat Rasayan Ltd. Stock Hits 52-Week Low Amid Continued Downtrend



Recent Price Movement and Market Context


On the day the new low was hit, Bharat Rasayan’s stock price fluctuated between an intraday high of Rs.1777 and the low of Rs.1647.15, closing with a day change of -2.03%. Despite this decline, the stock marginally outperformed its sector, which fell by -2.25%. The stock has been on a losing streak for four consecutive sessions, resulting in a cumulative return loss of -24.42% over this period.


Technical indicators show the stock trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — underscoring the prevailing bearish momentum. This contrasts with the broader market, where the Sensex, despite a negative opening and a fall of -206.74 points to 81,587.91 (-0.72%), remains above its 200-day moving average, though below its 50-day average. The Sensex has experienced a three-week consecutive decline, losing -4.87% in that timeframe.



Financial Performance and Profitability Trends


Bharat Rasayan’s recent quarterly results reveal a challenging environment. Profit Before Tax excluding other income (PBT LESS OI) declined sharply by -30.13% to Rs.27.23 crores. Net sales for the quarter fell by -12.78% to Rs.285.96 crores, while Profit After Tax (PAT) decreased by -13.3% to Rs.27.88 crores. These figures highlight a contraction in both top-line and bottom-line metrics, contributing to the stock’s downward pressure.


Over the last five years, the company’s operating profit has contracted at an annualised rate of -3.05%, indicating subdued long-term growth. This trend has been reflected in the stock’s performance, which has generated a negative return of -36.05% over the past year, significantly underperforming the Sensex’s positive 7.55% return during the same period. Furthermore, Bharat Rasayan has consistently lagged behind the BSE500 index in each of the last three annual periods.




Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!



  • - Hidden turnaround gem

  • - Solid fundamentals confirmed

  • - Large Cap opportunity


Discover This Hidden Gem →




Valuation and Efficiency Metrics


Despite the recent setbacks, Bharat Rasayan maintains certain financial strengths. The company exhibits a high return on equity (ROE) of 15.82%, reflecting efficient utilisation of shareholder capital. Additionally, the average debt-to-equity ratio remains low at 0.02 times, indicating a conservative capital structure with minimal leverage.


The stock’s price-to-book value ratio stands at 2.3, which is considered attractive relative to its peers’ historical valuations. This valuation discount may be indicative of market caution given the company’s recent earnings decline of -8.6% over the past year. Promoters continue to hold a majority stake, underscoring stable ownership.



Sectoral and Benchmark Comparisons


Within the Pesticides & Agrochemicals sector, Bharat Rasayan’s performance has been notably weaker. The sector itself has experienced a decline of -2.25% on the day the stock hit its 52-week low, but Bharat Rasayan’s four-day cumulative loss of -24.42% far exceeds sectoral movement. This divergence highlights company-specific factors influencing investor sentiment and price action.


Comparatively, the Sensex’s three-week decline of -4.87% and its current trading below the 50-day moving average reflect broader market headwinds, yet Bharat Rasayan’s underperformance remains pronounced.




Is Bharat Rasayan Ltd. your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!



  • - Better alternatives suggested

  • - Cross-sector comparison

  • - Portfolio optimization tool


Find Better Alternatives →




Rating and Market Perception


MarketsMOJO assigns Bharat Rasayan a Mojo Score of 28.0, categorising it with a Strong Sell grade as of 6 Jan 2026, an upgrade from the previous Sell rating. The company’s market capitalisation grade is rated 3, reflecting its mid-tier size within the sector. This rating adjustment underscores the ongoing concerns regarding the company’s growth trajectory and recent financial results.


The stock’s 52-week high was Rs.3030.25, illustrating the extent of the decline to the current low of Rs.1647.15. This nearly 46% drop from the peak price over the last year highlights the significant market revaluation the company has undergone.



Summary of Key Financial Indicators


To encapsulate, Bharat Rasayan’s recent quarterly figures show:



  • PBT LESS OI (Quarterly): Rs.27.23 crores, down -30.13%

  • Net Sales (Quarterly): Rs.285.96 crores, down -12.78%

  • PAT (Quarterly): Rs.27.88 crores, down -13.3%

  • Operating profit annualised decline over 5 years: -3.05%

  • Return on Equity: 15.82%

  • Debt to Equity ratio (average): 0.02 times

  • Price to Book Value: 2.3


These metrics collectively illustrate a company facing headwinds in growth and profitability, despite maintaining operational efficiency and a conservative balance sheet.



Broader Market and Sectoral Environment


The Pesticides & Agrochemicals sector has been under pressure, with sectoral declines contributing to the stock’s performance. The Sensex’s recent weakness further compounds the challenging environment for Bharat Rasayan. The stock’s sustained trading below all major moving averages signals continued caution among market participants.



Conclusion


Bharat Rasayan Ltd.’s fall to a new 52-week low of Rs.1647.15 reflects a combination of subdued financial results, sectoral pressures, and broader market weakness. While the company retains strengths in management efficiency and capital structure, the persistent decline in sales and profits has weighed heavily on its market valuation. The stock’s performance relative to benchmarks and peers highlights the challenges faced over the past year and the cautious stance adopted by investors.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News